Navigation Links
Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP
Date:5/20/2008

NASHVILLE, Tenn., May 20 /PRNewswire/ -- Ambulatory Services of America, Inc. announced the formation of ROSA of Denton, LLP, its fourth joint venture to provide outpatient radiation oncology services. ROSA of Denton is a joint venture between Denton Cancer Center, LP and ASA's subsidiary, Radiation Oncology Services of America, Inc. ROSA of Denton will own and operate a radiation therapy facility in Denton, Texas that was previously owned and operated by Denton Cancer Center.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071218/CLTU087LOGO )

ROSA of Denton will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT) in the Denton center. The joint venture expects to build on Denton Cancer Center's legacy of providing high-quality cancer care to the residents of the north Dallas area. Tahir Rana, M.D. will serve as medical director for ROSA of Denton.

Dr. Rana, M.D., founder of Denton Cancer Center, said, "I am happy to join with ASA and ROSA. Their management team brings a strong commitment to providing high quality care to patients, and I believe they will be good partners to continue Denton Cancer Center's commitment to caring for cancer patients."

Timothy Martin, President and Chief Executive Officer of ASA, said, "We are excited about the continued growth of our radiation therapy business and our partnership with Dr. Rana and Denton Cancer Center. We look forward to providing excellent care for cancer patients in Denton and the north Dallas area and to working with Dr. Rana to promote the growth and success of ROSA of Denton."

Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians. ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Renal Services of America, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services. After the acquisition, ASA will own interests in and operate 38 dialysis centers and 11 radiation oncology centers in eight states and the territory of Guam. ASA also manages three other dialysis centers.


'/>"/>
SOURCE Ambulatory Services of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
2. Ambulatory Services of America, Inc. Announces Joint Venture with Southern Ocean County Radiation Oncology, LLC
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. GE and Satyam Announce Global Alliance to Provide Healthcare IT Services
7. Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy
8. Best Practices Insurance Services Announces Key Additions to Senior Management
9. Lakewood Pathology Launches National Gastroinestinal Diagnostic Services
10. PA Secretary of Health Announces Emergency Medical Services Week, May 18 - 24
11. TetraQ recognized for toxicology services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... ... it will co-exhibit with technology partners LG Business Solutions at ATARC Federal ... Center in Washington D.C., will provide education and examination into the mobility tools ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, ... coverage on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business ... the April edition of American Veterinarian™. , “We look forward to ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, a leading provider ... a row; they are the recipient of the prestigious “Best Overall Design Strategy ... award at Design Connections 2017. Top A&D professionals from leading firms, furniture manufacturers ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... testing methods are complicated and require expert user knowledge. In a live webinar ... dedicated to the simplified, yet highly accurate, determination of sodium. , It has ...
(Date:3/27/2017)... Fla. (PRWEB) , ... March 27, 2017 , ... The ... and the number of homeowners utilizing DIY and unlicensed contractors for renovations is also ... remodel or replacement project in 2015, and of those, 42% failed to use a ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , ... a leading global pharmaceutical company and Paratek Pharmaceuticals, ... the development and commercialization of innovative therapies based ... 3 trials of sarecycline for the treatment of ... primary efficacy endpoints. Sarecycline is a once-daily, oral, ...
(Date:3/27/2017)... 2017  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical ... diseases in children, today reported financial results for ... 31, 2016 and provided an update on its ... make progress during the fourth quarter of 2016 ... primate safety study, and with our lead development ...
(Date:3/24/2017)... Research and Markets has announced the ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 report ... cell therapy manufacturing and focuses both on contract manufacturers and ... anticipated to emerge as viable alternatives to conventional treatment options. ...
Breaking Medicine Technology: